Changes in bone turnover markers with HIV seroconversion and ART initiation.

about

Changes in bone turnover markers with HIV seroconversion and ART initiation.

Item

http://www.wikidata.org/entity/Q38973122

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Changes in bone turnover markers with HIV seroconversion and ART initiation.

@en

type

Item

label

Changes in bone turnover markers with HIV seroconversion and ART initiation.

@en

prefLabel

Changes in bone turnover markers with HIV seroconversion and ART initiation.

@en

P1476

Changes in bone turnover markers with HIV seroconversion and ART initiation.

@en

P2093

Frank J Palella

http://www.w3.org/2001/XMLSchema#string

John Phair

http://www.w3.org/2001/XMLSchema#string

Laurence Slama

http://www.w3.org/2001/XMLSchema#string

Multicenter AIDS Cohort Study group (MACS)

http://www.w3.org/2001/XMLSchema#string

Susheel Reddy

http://www.w3.org/2001/XMLSchema#string

Todd T Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

Vitamin D-binding protein and vitamin D status of black Americans and white Americans

Incident fractures in HIV-infected individuals: a systematic review and meta-analysis

Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

A review of osteocyte function and the emerging importance of sclerostin

A pooled analysis of vitamin D dose requirements for fracture prevention.

Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.

P304

1456-1461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX011

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28175307

http://www.w3.org/2001/XMLSchema#string

P921

seroconversion

P932

5890782

http://www.w3.org/2001/XMLSchema#string